InvestorsHub Logo
Followers 94
Posts 11292
Boards Moderated 0
Alias Born 11/02/2003

Re: None

Wednesday, 10/07/2020 7:37:21 PM

Wednesday, October 07, 2020 7:37:21 PM

Post# of 9951
Does Provectus have the capability with its patented PV10 technology to piggyback half-life radiotherapy on its platform to selectively kill cancers in the body? If so this is not just a one-trick pony show. We are looking at a billion-dollar company unfolding right before our eyes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News